Clinical trial
Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease…
NCT00400504 · Rigshospitalet, Denmark, Other · Unknown status
Key facts
| NCT number | NCT00400504 |
|---|---|
| Title | Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®) |
| Official title | Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®) |
| Lead sponsor | Rigshospitalet, Denmark, Other |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Cancer |
| Enrollment | 500 |
| Start date | Nov 1, 2006 |
| First posted | Nov 17, 2006 |
| Last update posted | Nov 17, 2006 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: